National Cancer Institute; Notice of Closed Meetings

• Published date: 01 August 2019
• Citation: 84 FR 37656
• Record Number: 2019-16446
• Section: Notices
• Court: National Institutes Of Health

Federal Register, Volume 84 Issue 148 (Thursday, August 1, 2019)

[Federal Register Volume 84, Number 148 (Thursday, August 1, 2019)]
                [Notices]
                [Page 37656]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-16446]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Cancer Institute; Notice of Closed Meetings
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of the following meetings.
                 The meetings will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The grant applications and the discussions could
                disclose confidential trade secrets or commercial property such as
                patentable material, and personal information concerning individuals
                associated with the grant applications, the disclosure of which would
                constitute a clearly unwarranted invasion of personal privacy.
                 Name of Committee: National Cancer Institute Special Emphasis
                Panel; Innovative Molecular Analysis Technologies.
                 Date: September 19, 2019.
                 Time: 9:00 a.m. to 4:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Cancer Institute, Shady Grove, 9609 Medical
                Center Drive, Room 7W260, Rockville, MD 20850 (Telephone Conference
                Call).
                 Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
                Research Technology and Contract Review Branch, Division of
                Extramural Activities, 9609 Medical Center Drive, Room 7W260,
                National Cancer Institute, NIH, Bethesda, MD 20892-9745, (240) 276-
                5856, [email protected].
                 Name of Committee: National Cancer Institute Special Emphasis
                Panel; Program Project 1.
                 Date: September 19-20, 2019.
                 Time: 5:00 p.m. to 5:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: Hilton Washington/Rockville, 1750 Rockville Pike
                Rockville, MD 20852.
                 Contact Person: Clifford W Schweinfest, Ph.D., Scientific Review
                Officer, Special Review Branch, Division of Extramural Activities,
                National Cancer Institute, NIH, 9609 Medical Center Drive, Room
                7W108, Bethesda, MD 20892-8329, 240-276-6343,
                [email protected].
                 Name of Committee: National Cancer Institute Special Emphasis
                Panel; Traceback Testing: Outreach for Genetic Counseling of
                Mutation Carriers.
                 Date: September 25, 2019.
                 Time: 1:00 p.m. to 4:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Cancer Institute Shady Grove, 9609 Medical
                Center Drive, Room 7W234, Rockville, MD 20850 (Telephone Conference
                Call).
                 Contact Person: Adriana Stoica, Ph.D., Scientific Review
                Officer, Resources and Training Review Branch, Division of
                Extramural Activities, National Cancer Institute, NIH, 9609 Medical
                Center Drive, Room 7W234, Bethesda, MD 20892-9750, 240-276-6368,
                [email protected].
                (Catalogue of Federal Domestic Assistance Program Nos. 93.392,
                Cancer Construction; 93.393, Cancer Cause and Prevention Research;
                93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
                Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
                Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
                Control, National Institutes of Health, HHS)
                 Dated: July 29, 2019.
                Melanie J. Pantoja,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2019-16446 Filed 7-31-19; 8:45 am]
                 BILLING CODE 4140-01-P